Similar results were observed in an experimental model of heart failure, from which increased TGF-β1 expression and atrial fibrosis were reported [11,15], and pirfenidone treatment resulted in a significant reduction of TGF-β1 expression and atrial fibrosis. Here, TGFB1 is linked to heart failure.